Study of Metformin Pharmacogenetics in Twins
- Registration Number
- NCT01869621
- Lead Sponsor
- University of Southern Denmark
- Brief Summary
The trough concentration of metformin will be examined in monozygotic and dizygotic twins. Current twin study will determine the total weight of genetics on the trough concentration of metformin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34
- Age 18-40 years
- Both twins has to be included
- Dizygotic twin pairs has to be same sex
- Informed consent given
- Healthy condition
- Chronical/daily alcohol abuse
- Hypersensitivity to metformin
- Ingestion of drugs containing topiramate or x-ray contrast fluids
- For women: Positive pregnancy test/breastfeeding at the beginning of the trial. No use of safe anticonceptives
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Metformin Metformin 6 days treatment with metformin
- Primary Outcome Measures
Name Time Method Heritability After 6 days of metformin treatment The trough concentrations of metformin in twin pairs will be used to determine the effect of heritability on metformin trough concentrations. This will give insight to the weight that genetic factors have on metformin pharmacokinetics at steady-state.
- Secondary Outcome Measures
Name Time Method Single nucleotide polymorphisms (SNPs) After 6 days treatment with metformin The effect of SNPs on trough metformin concentration
Trial Locations
- Locations (1)
Clinical Pharmacology
🇩🇰Odense C, Denmark